Sponsor:
Vanderbilt University Medical Center
Code:
NCT06576726
Conditions
Tourette Syndrome
Tic Disorder
Eligibility Criteria
Sex: All
Age: 11 - 17
Healthy Volunteers: Accepted
Interventions
This study involves no intervention.
Brief summary:
Conditions
Tourette Syndrome
Tic Disorder
Study ID
NCT06576726
Start date
Oct 24, 2024
Status verified date
Nov, 2025
Completion date
May, 2030
Anticipated
Primary completion date
Aug, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 11 - 17
Healthy Volunteers: Accepted
Enrollment
351 participants
Anticipated
Arms
adolescents with tic disorder
neurotypical adolescents (controls)
Interventions
This study involves no intervention.
Primary outcome measure
Central contacts
Locations
Vanderbilt University Medical Center
Recruiting
Nashvile, Tennessee, United States, 37232
Contacts
Michelle Clinical Translational Research Coordinator II, BS
615-875-7394michelle.r.eckland.1@vumc.orgPrincipal Investigator:
David Isaacs, MD, MPH
Sponsor
Vanderbilt University Medical Center
Last update posted
Nov 24, 2025
Last verified
Nov, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Vanderbilt University Medical Center on 2025-11-24.